Thierry Maudelonde
Overview
Explore the profile of Thierry Maudelonde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacot W, Mazel M, Mollevi C, Pouderoux S, DHondt V, Cayrefourcq L, et al.
Clin Chem
. 2020 Jul;
66(8):1093-1101.
PMID: 32712650
Background: Data regarding the prognostic value of programmed cell death ligand 1 (PD-L1) expression on circulating tumor cells (CTCs) are lacking. However, CTCs could represent an alternative approach to serial...
2.
Vendrell J, Solassol J, Gyorffy B, Vilquin P, Jarlier M, Donini C, et al.
Front Pharmacol
. 2019 Feb;
9:1581.
PMID: 30740056
is a candidate oncogene with a wide variety of deleterious functions in breast cancer. Here, we aimed at investigating in a pilot prospective study the association between mRNA expression levels...
3.
Tifaoui N, Maudelonde T, Combecal J, Vallo R, Doutre S, Didelot M, et al.
J Clin Virol
. 2018 Sep;
108:12-18.
PMID: 30196012
Background: With population ageing, post-menopausal women represent a new group to be considered in cervical cancer screening strategies, including the significance of High Risk (HR)-HPV detection. Objectives: A retrospective analysis...
4.
Rey J, Ducros V, Pujol P, Wang Q, Buisine M, Aissaoui H, et al.
J Mol Diagn
. 2017 May;
19(4):589-601.
PMID: 28502729
Identification of genetic alterations is important for family risk assessment in colorectal cancers. Next-generation sequencing (NGS) technologies provide useful tools for single-nucleotide and copy number variation (CNV) identification in many...
5.
Alix-Panabieres C, Cayrefourcq L, Mazard T, Maudelonde T, Assenat E, Assou S
Clin Chem
. 2016 Dec;
63(3):700-713.
PMID: 28007957
Background: Unraveling the molecular mechanisms that regulate the biology of metastasis-competent circulating tumor cells (CTCs) is urgently needed to understand metastasis formation and tumor relapse. Our group previously established the...
6.
Frouin E, Maudelonde T, Senal R, Larrieux M, Costes V, Godreuil S, et al.
PLoS One
. 2016 Jul;
11(7):e0158698.
PMID: 27466810
Genotyping BRAF in melanoma samples is often challenging. The presence of melanin greatly interferes with thermostable DNA polymerases and/or nucleic acids in traditional polymerase chain reaction (PCR)-based methods. In the...
7.
Lapierre M, Linares A, Dalvai M, Duraffourd C, Bonnet S, Boulahtouf A, et al.
Oncotarget
. 2016 Mar;
7(15):19693-708.
PMID: 26930713
Histone lysine acetylation is an epigenetic mark regulated by histone acetyltransferases and histone deacetylases (HDAC) which plays an important role in tumorigenesis. In this study, we observed a strong overexpression...
8.
Mazel M, Jacot W, Pantel K, Bartkowiak K, Topart D, Cayrefourcq L, et al.
Mol Oncol
. 2015 Jun;
9(9):1773-82.
PMID: 26093818
Immune checkpoint regulators such as PD-L1 have become exciting new therapeutic targets leading to long lasting remissions in patients with advanced malignancies. However, in view of the remarkable costs and...
9.
Vilquin P, Cohen P, Maudelonde T, Tredan O, Treilleux I, Bachelot T, et al.
Bull Cancer
. 2015 Mar;
102(4):367-80.
PMID: 25799877
Hormone-dependent breast cancer is the first example of cancer treated by targeted therapy for more than 30 years. Blocking estrogen pathway was the first therapeutical strategy for this subtype of...
10.
Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, et al.
Cancer Res
. 2015 Jan;
75(5):892-901.
PMID: 25592149
Circulating tumor cells (CTC) in blood are promising new biomarkers potentially useful for prognostic prediction and monitoring of therapies in patients with solid tumors including colon cancer. Moreover, CTC research...